1995
DOI: 10.1007/bf00169394
|View full text |Cite
|
Sign up to set email alerts
|

Functional serotonin 5-HT1D receptors and 5-HT1D? receptor mRNA expression in human umbilical vein endothelial cells

Abstract: Pharmacological evidence has suggested the presence of 5-hydroxytryptamine (5-HT, serotonin), 5-HT1D receptors on endothelial cells but these receptors have never been identified unambiguously on this type of cells. We now report that human umbilical vein endothelial cells (HUVEC) express 5-HT1D receptors coupled to inhibition of cyclic AMP formation. 5-HT and the 5-HTlo receptor agonists 5-carboxamidotryptamine (5-CT) and sumatriptan were approximately equipotent at inhibiting forskolin-stimulated cyclic AMP … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
9
0

Year Published

1995
1995
2014
2014

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 14 publications
0
9
0
Order By: Relevance
“…Furthermore, the presence of 5-HTID receptors on endothelial cells has recently been demonstrated (Schoeffter et al, 1995). Our results suggest that the efficacy, but not the potency of 5-HT, 5-CT and Sum in evoking contractile responses of rabbit saphenous vein rings are largely subject to an inhibitory influence of the E and of an EDRF which is probably NO.…”
Section: -Htid Receptor Agonist Efficaciesmentioning
confidence: 50%
See 1 more Smart Citation
“…Furthermore, the presence of 5-HTID receptors on endothelial cells has recently been demonstrated (Schoeffter et al, 1995). Our results suggest that the efficacy, but not the potency of 5-HT, 5-CT and Sum in evoking contractile responses of rabbit saphenous vein rings are largely subject to an inhibitory influence of the E and of an EDRF which is probably NO.…”
Section: -Htid Receptor Agonist Efficaciesmentioning
confidence: 50%
“…Furthermore, the presence of 5-HTID receptors on endothelial cells has recently been demonstrated (Schoeffter et al, 1995 (Clitherow et al, 1994;Skingle et al, 1994) surmountably antagonized the contractile responses evoked by 5-HT and Sum, again suggesting interaction with a single receptor population. This is corroborated by the Schild analyses which gave slopes near unity (1.04 and 0.93, respectively).…”
Section: -Htid Receptor Agonist Efficaciesmentioning
confidence: 80%
“…Although 5-HTloB receptors are expressed in these cells, it should be noted, that the pharmacology of this relaxation was similar but not identical to that of the cloned 5-HT~D~ or 5-HT~Dp receptors. Based on experiments performed with the cloned heterologously expressed 5-HT~Dp receptors [27] and with human endothelial cells from the umbilical vein [28], the 5-HT1D~ receptor inhibits cAMP formation. The endothelium dependent relaxation had previously been shown to be sensitive to pertussis toxin [29], which is in agreement with a G~-protein mediated inhibition of adenylate cyclase.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly in human basilar and coronary arteries, sumatriptan is less potent than 5‐HT ( Boulanger et al ., 1995 ; Connor et al ., 1989 ; Parsons et al ., 1989 ). However, a very high potency, pEC 50 8.2±0.2, even higher than that of 5‐HT, for sumatriptan is seen in human umbilical vein endothelial cells ( Schoeffter et al ., 1995 ). 5‐nonyloxytryptamine binds at human 5‐HT 1B/1D receptors with about five times higher affinity than sumatriptan, K i =1.2 and 5.5 n M , respectively ( Glennon et al ., 1994 ).…”
Section: Discussionmentioning
confidence: 99%